RN7SL832P

Across TCGA pan-cancer cohorts, RN7SL832P RNA differs between tumor and matched normal tissue in 10 of 18 cancer types tested, making tumor–normal expression one of RN7SL832P’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where RN7SL832P RNA is repressed in tumor relative to normal tissue. In most cancer types RN7SL832P is over-expressed in tumor, although a few such as KIRC and THCA show the opposite, repressed pattern.

KIRC, THCA, and KICH are the cancer types where RN7SL832P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL832P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	II,III,IV	−1.024	<.001	11	view →
THCA	Male	III,IV	−1.017	<.001	11	view →
KICH	Male	All	−2.043	<.001	8	view →
BRCA	Female	II,III,IV	−0.370	<.001	6	view →
KIRP	All	All	−0.655	<.001	5	view →
BLCA	All	All	+0.585	.021	5	view →
LUSC	All	All	+0.455	<.001	5	view →
LIHC	All	All	+0.259	<.001	5	view →
CHOL	All	All	+0.294	.006	4	view →
HNSC	Male	III,IV	+0.363	.008	3	view →
BLCA	Male	IV	−0.545	.005	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 11 strongest of 10 lineages.

RN7SL832P–KIRC

Open the KIRC breakdown →